Focus on Clinical Documentation for Improved Patient Care and Reimbursement Revenue CHICAGO, July 17, 2018 /PRNewswire/ — The AHIMA World Congress (AWC) announced that Al Ain Continue Reading
SQN Clinical Launches the Most Advanced Real-time Analytics Tool for Clinical Research
DISS, England, July 17, 2018 /PRNewswire/ — SQN Clinical launches SQN Health Analytics, providing clinical professionals with a clear picture of the entire trial process Continue Reading
Aurigene Announces First in Human Dosing with RoRγt Inverse Agonist AUR-101
BOSTON, July 12, 2018 /PRNewswire/ — – Phase 1 data from the study expected to be available by December 2018 Aurigene, a biotechnology company focused Continue Reading
FARO® Announces Acquisition of Open Technologies
Extends 3D Capabilities Into Dental and Across a Variety of Design Driven Industries LAKE MARY, Fla., July 16, 2018 /PRNewswire/ — FARO® (NASDAQ: FARO), the world’s Continue Reading
Editor’s Note: Ideal Body
Everybody has their own ideal body shape that they want to achieve. Some want their body to be muscular, lean, toned and much more. There Continue Reading
CStone’s PD-1 inhibitor CS1003 receives clinical trial approval in China
SUZHOU, China, July 12, 2018 /PRNewswire/ — CStone Pharmaceuticals (SuZhou) Co. LTD (CStone), a privately-held biopharmaceutical company devoted to developing next-generation innovative drugs, announced today Continue Reading
Merck Announces Collaboration with Xian Janssen to Launch INVOKANA(R) (canagliflozin) for the Treatment of Type 2 Diabetes in China
BEIJING, July 12, 2018 /PRNewswire/ — Merck, a leading science and technology company, signed an agreement with Xian Janssen Pharmaceuticals Ltd. in Beijing on July 11, Continue Reading
SK Holdings to Acquire AMPAC Fine Chemicals (AFC), a Leading Contract Development and Manufacturing Organization (CDMO)
– Combination significantly strengthens SK’s CDMO growth platform – AFC provides entry into the US, the world’s largest CDMO market, positioning the combination as a Continue Reading
PureCircle Has Vastly Increased Its Capacity To Supply Reb M to the Beverage and Food Industries
Enough to Sweeten 500 Million Cases of Carbonated Soft Drinks or the Equivalent Cost Comparable to Sugar CHICAGO, July 13, 2018 /PRNewswire/ — PureCircle (LSE: PURE), the world’s Continue Reading
OrigiMed Collaborates with Illumina to Further Develop and Promote its Advanced Clinical Molecular Tumor Applications
SHANGHAI, July 13, 2018 /PRNewswire/ — OrigiMed announces an agreement with Illumina in Shanghai, China. It will develop and promote its advanced molecular clinical tumor Continue Reading